ClinicalTrials.gov record
Active, not recruiting Phase 1 Interventional

Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients

ClinicalTrials.gov ID: NCT02500849

Public ClinicalTrials.gov record NCT02500849. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 11:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pilot Study to Evaluate the Feasibility, Safety and Engraftment of Zinc Finger Nuclease (ZFN) CCR5 Modified CD34+ Hematopoietic Stem/Progenitor Cells (SB-728mR-HSPC) in HIV-1 (R5) Infected Patients

Study identification

NCT ID
NCT02500849
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
City of Hope Medical Center
Other
Enrollment
12 participants

Conditions and interventions

Conditions

Interventions

  • SB-728mR-HSPC Infusion 3 days following busulfan conditioning Genetic

Genetic

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 9, 2016
Primary completion
Aug 23, 2026
Completion
Aug 23, 2026
Last update posted
Oct 8, 2025

2016 – 2026

United States locations

U.S. sites
5
U.S. states
2
U.S. cities
4
Facility City State ZIP Site status
City of Hope Medical Center Duarte California 91010
UCLA CARE Center Los Angeles California 90035
Mills Clinical Research Los Angeles California 90069
Quest Clinical Research San Francisco California 94115
Circle CARE Center, LLC Norwalk Connecticut 06850

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02500849, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2025 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02500849 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →